• About
  • Products & Solutions
    hStroke Suite
    hStroke CT hStroke LVO hStroke DWI hStroke CTP
    hprostate
    hProstate
    hchestxr
    hChestXR
    hbreastmmg
    hBreastMMG

    Hevi AI offers revolutionary artificial intelligence-based solutions in the healthcare sector. Our product range includes specially designed systems such as hStroke, hProstate, hChestX and hBreastMMG. Each contributes to enhancing medical imaging and diagnostic processes, aiding in achieving faster and more accurate results.

  • News
  • Book a Demo
  • About
  • Productions & Solutions
    Product & Solutions
    hStroke Suite
    hStroke CT hStroke LVO hStroke DWI hStroke CTP
    hProstate
    hChestXR
    hBreastMMG

    Hevi.ai offers revolutionary artificial intelligence-based solutions in the healthcare sector. Our product range includes specially designed systems such as hStroke, hProstate, hChestX and hBreastMMG. Each contributes to enhancing medical imaging and diagnostic processes, aiding in achieving faster and more accurate results.

  • News
  • Book a Demo
Home
News
Advancements in Prostate Cancer Detection with Self-Adapting Deep Neural Networks
Advancements in Prostate Cancer Detection with Self-Adapting Deep Neural Networks
Facebook
Linkedin
Twitter
Instagram
Youtube
Anatomically guided self-adapting deep neural network for clinically significant prostate cancer detection on bi-parametric MRI: a multi-center study

Our team members have made significant contributions to a pivotal multicenter study, titled "Anatomically Guided Self-Adapting Deep Neural Network for Clinically Significant Prostate Cancer Detection on Bi-parametric MRI: A Multi-Center Study." This research highlights the effectiveness of a self-adapting deep neural network, specifically designed to detect clinically significant prostate cancer (csPCa) using bi-parametric MRI scans from a diverse male demographic.

 

The study concluded that the deep learning method, employing prostate masks trained on extensive bi-parametric MRI datasets, maintains high performance in detecting csPCa in both internal and external datasets, showcasing the robustness and generalizability of deep learning applications across varied datasets.

 

This self-adapting deep network exemplifies the potential of advanced deep learning methods to improve the detection of clinically significant prostate cancer in diverse clinical settings, promising substantial enhancements in clinical diagnostics.

 

At Hevi AI, we are dedicated to advancing scientific research and improving the accuracy and functionality of AI technologies in medical imaging. For more in-depth information about this study, please visit [SpringerLink](https://link.springer.com/article/10.1186/s13244-023-01439-0).

 

 

Share This Post:
  • Home
  • About
  • FAQS
  • Contact
info@hevi.ai
|
İçerenköy Mh. Acıbadem Üniv. Tıp Fakültesi No: 32-36B Ataşehir/İstanbul

Learn More About Our AI-Powered Solutions: Schedule a Demo Today
© 2024 Hevi AI - All Rights Reserved.
PDPL Policy | Information Security | Clarification Text | Storage&Disposal

This website uses cookies to enhance user experience and provide services. To learn more, please visit our Cookies Policy page.